News & Updates

MOSAIC updates: MRI outcomes bolster apremilast role in PsA dactylitis

27 Jun 2025 by

Apremilast, an oral immunomodulating phosphodiesterase-4 inhibitor, reduces inflammation in individual joints and clinical dactylitis as per MRI in patients with psoriatic arthritis (PsA), according to the results of a dynamic contrast-enhanced MRI (DCE-MRI) analysis of the phase IV, open-label MOSAIC study.

MOSAIC updates: MRI outcomes bolster apremilast role in PsA dactylitis

27 Jun 2025

Anifrolumab may enhance quality of life in lupus

27 Jun 2025

Patients with systemic lupus erythematosus (SLE) treated with anifrolumab over 4 years appear to report improvements in health status and quality of life, according to data from the TULIP long-term extension trial (TULIP-LTE).

Anifrolumab may enhance quality of life in lupus

27 Jun 2025

Sugary, artificially sweetened beverages pose no risk of dementia in older adults

26 Jun 2025

Increased intake of sugar-sweetened beverages (SSB) or artificially sweetened beverages (ASB) does not appear to contribute to the risk of dementia in older adults, according to a study.

Sugary, artificially sweetened beverages pose no risk of dementia in older adults

26 Jun 2025

Is anal cancer screening in MSM with HIV worth the buck?

26 Jun 2025

Screening for anal cancer among men who have sex with men (MSM) with HIV aged ≥35 years is cost-effective, according to a recent study. However, there is a need for value-based prioritization strategies to improve screening use.

Is anal cancer screening in MSM with HIV worth the buck?

26 Jun 2025

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025 by

The presence of diabetes mellitus predisposes patients with chronic hepatitis B (CHB) to a higher risk of developing hepatocellular carcinoma (HCC), reveals a study presented at EASL 2025.

Diabetes in CHD patients ups risk of hepatocellular carcinoma

26 Jun 2025

Semaglutide superior to empagliflozin in lowering mortality, CV risks in T2D patients

26 Jun 2025

Treatment with semaglutide may offer some advantage over empagliflozin, with a recent study showing a much lower risk of death and cardiovascular (CV) events among patients with type 2 diabetes (T2D) who received semaglutide.

Semaglutide superior to empagliflozin in lowering mortality, CV risks in T2D patients

26 Jun 2025

Add-on obinutuzumab yields robust treatment benefit in lupus nephritis

26 Jun 2025 by

In a post hoc analysis using the phase III REGENCY study dataset, obinutuzumab on top of standard therapy (ST) demonstrates significant superiority to placebo plus ST across numerous renal response definitions in patients with active lupus nephritis (LN).

Add-on obinutuzumab yields robust treatment benefit in lupus nephritis

26 Jun 2025

More than 200 pharmacists meet for empowering leadership event

26 Jun 2025

The Pharmacists Healthcare Leadership Forum (PHLF) 2025, organised by the Malaysian Pharmacists Society’s Hospital and Clinical Pharmacy Chapter in collaboration with the Community Pharmacy Chapter and the Community Public Awareness Chapter, was a remarkable success.

More than 200 pharmacists meet for empowering leadership event

26 Jun 2025

Chronodisruption may interfere with conception in women desiring pregnancy

26 Jun 2025

Among women hoping to get pregnant, greater day-to-day variability in sleep onset and duration—both indicators of chronodisruption—are linked to a longer time to conception over a year of follow-up, as reported in a study.

Chronodisruption may interfere with conception in women desiring pregnancy

26 Jun 2025

AF events may soar up to threefold in extreme heat

25 Jun 2025 by

High outdoor temperatures may predispose individuals to atrial fibrillation (AF), with the odds increasing two- to threefold at extremely high temperature levels, according to a study.

AF events may soar up to threefold in extreme heat

25 Jun 2025

News & Updates

Filter by Specialty:

Specialty:

MOSAIC updates: MRI outcomes bolster apremilast role in PsA dactylitis

MOSAIC updates: MRI outcomes bolster apremilast role in PsA dactylitis

Anifrolumab may enhance quality of life in lupus

Anifrolumab may enhance quality of life in lupus

Sugary, artificially sweetened beverages pose no risk of dementia in older adults

Sugary, artificially sweetened beverages pose no risk of dementia in older adults

Is anal cancer screening in MSM with HIV worth the buck?

Is anal cancer screening in MSM with HIV worth the buck?

Diabetes in CHD patients ups risk of hepatocellular carcinoma

Diabetes in CHD patients ups risk of hepatocellular carcinoma

Semaglutide superior to empagliflozin in lowering mortality, CV risks in T2D patients

Semaglutide superior to empagliflozin in lowering mortality, CV risks in T2D patients

Add-on obinutuzumab yields robust treatment benefit in lupus nephritis

Add-on obinutuzumab yields robust treatment benefit in lupus nephritis

More than 200 pharmacists meet for empowering leadership event

More than 200 pharmacists meet for empowering leadership event

Chronodisruption may interfere with conception in women desiring pregnancy

Chronodisruption may interfere with conception in women desiring pregnancy

AF events may soar up to threefold in extreme heat

AF events may soar up to threefold in extreme heat